Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

85.99 

1.83 2.2%

as of Apr 09 '21

52 Week Range:

66.23 92.08


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 1.90
1.98
2.16
2.19
3.16
3.75
4.24
5.03
5.39
6.08
6.74
growth rate 4.2% 9.1% 1.4% 44.3% 18.7% 13.1% 18.6% 7.2% 12.8% 10.9%
Earnings BIT 268.20
283.60
391.10
515.30
494.80
642.90
819.40
1,022.40
1,072.80
1,240.50
1,316.20
growth rate 5.7% 37.9% 31.8% -4.0% 29.9% 27.5% 24.8% 4.9% 15.6% 6.1%
Avg.PE 44.25
35.71
36.36
19.12
17.78
39.08
36.31
46.77
52.25
67.45
63.52
growth rate -19.3% 1.8% -47.4% -7.0% 119.8% -7.1% 28.8% 11.7% 29.1% -5.8%
ROA 12.89
12.63
13.96
15.84
25.96
13.05
13.29
11.44
13.11
17.73
12.00
growth rate -2.0% 10.5% 13.5% 63.9% -49.7% 1.8% -13.9% 14.6% 35.2% -32.3%
ROE 17.68
17.89
20.82
25.78
43.25
21.08
22.24
20.94
23.69
28.73
18.88
growth rate 1.2% 16.4% 23.8% 67.8% -51.3% 5.5% -5.9% 13.1% 21.3% -34.3%
ROIC 17.20
16.05
18.56
20.71
33.14
17.05
17.60
14.58
20.21
24.14
16.18
growth rate -6.7% 15.6% 11.6% 60.0% -48.6% 3.2% -17.2% 38.6% 19.5% -33.0%
Cur. Ratio 3.06
3.49
3.72
4.99
5.28
4.30
4.21
1.80
2.61
3.31
3.46
growth rate 14.1% 6.6% 34.1% 5.8% -18.6% -2.1% -57.2% 45.0% 26.8% 4.5%
Quick Ratio 2.07
2.30
2.50
3.66
4.06
3.29
3.17
1.28
1.70
2.34
2.24
growth rate 11.1% 8.7% 46.4% 10.9% -19.0% -3.7% -59.6% 32.8% 37.7% -4.3%
Leverage 1.35
1.48
1.50
1.75
1.61
1.62
1.72
1.93
1.70
1.56
1.58
growth rate 9.6% 1.4% 16.7% -8.0% 0.6% 6.2% 12.2% -11.9% -8.2% 1.3%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 277.30
364.60
390.90
361.40
325.00
371.80
414.60
479.30
537.30
599.10
602.80
growth rate 31.5% 7.2% -7.6% -10.1% 14.4% 11.5% 15.6% 12.1% 11.5% 0.6%
Acct.Payable 335.20
347.40
345.60
58.20
63.90
97.10
116.60
134.00
180.40
196.50
growth rate 3.6% -0.5% -83.2% 9.8% 52.0% 20.1% 14.9% 34.6% 8.9%
Cur.Assets 1,032.60
1,168.50
1,291.90
1,725.80
2,231.10
2,047.90
2,240.00
2,549.20
2,286.90
2,984.00
3,091.00
growth rate 13.2% 10.6% 33.6% 29.3% -8.2% 9.4% 13.8% -10.3% 30.5% 3.6%
Total Assets 1,767.20
1,980.50
2,221.50
2,709.90
3,523.00
4,056.30
4,510.00
5,666.40
5,323.70
6,488.10
7,237.10
growth rate 12.1% 12.2% 22.0% 30.0% 15.1% 11.2% 25.6% -6.1% 21.9% 11.5%
Cash 396.10
171.20
310.90
420.40
653.80
718.40
930.10
818.30
714.10
1,179.10
1,183.20
growth rate -56.8% 81.6% 35.2% 55.5% 9.9% 29.5% -12.0% -12.7% 65.1% 0.4%
Inventory 203.60
261.30
281.00
308.90
296.80
339.90
396.60
554.90
607.00
640.90
802.30
growth rate 28.3% 7.5% 9.9% -3.9% 14.5% 16.7% 39.9% 9.4% 5.6% 25.2%
Cur.Liabilities 337.80
335.20
347.40
345.60
426.10
476.20
532.50
1,420.00
876.60
902.40
893.90
growth rate -0.8% 3.6% -0.5% 23.3% 11.8% 11.8% 166.7% -38.3% 2.9% -0.9%
Liabilities 459.00
642.60
742.20
1,165.50
1,331.60
1,553.20
1,891.00
2,710.20
2,183.30
2,339.80
2,662.80
growth rate 40.0% 15.5% 57.0% 14.3% 16.6% 21.8% 43.3% -19.4% 7.2% 13.8%
LT Debt 0.00
150.40
189.30
593.10
598.10
596.90
822.30
438.40
593.80
594.40
595.00
growth rate 25.9% 213.3% 0.8% -0.2% 37.8% -46.7% 35.5% 0.1% 0.1%
Equity 1,308.20
1,337.90
1,479.30
1,544.40
2,191.40
2,503.10
2,619.00
2,956.20
3,140.40
4,148.30
4,574.30
growth rate 2.3% 10.6% 4.4% 41.9% 14.2% 4.6% 12.9% 6.2% 32.1% 10.3%
Common Shares 715.00
716.00
709.00
682.00
651.00
660.00
653.00
648.00
640.00
637.00
631.00
growth rate 0.1% -1.0% -3.8% -4.6% 1.4% -1.1% -0.8% -1.2% -0.5% -0.9%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 63.00
76.60
109.00
109.00
82.90
102.70
176.10
168.10
238.70
254.40
407.00
growth rate 21.6% 42.3% 0.0% -23.9% 23.9% 71.5% -4.5% 42.0% 6.6% 60.0%
Cash Dividends 0.00 0.00 0.00
growth rate
Cash From OA 251.40
308.20
362.10
472.70
1,022.30
549.70
704.40
1,000.70
926.70
1,182.90
1,054.30
growth rate 22.6% 17.5% 30.5% 116.3% -46.2% 28.1% 42.1% -7.4% 27.7% -10.9%
FCF per Share 0.26
0.27
0.35
0.49
1.49
0.65
0.63
1.00
1.18
1.27
1.09
growth rate 3.9% 29.6% 40.0% 204.1% -56.4% -3.1% 58.7% 18.0% 7.6% -14.2%
Sale Purchase of Stock -243.90
-244.00
-451.40
113.30
87.20
103.30
113.80
growth rate 0.0% 0.0% 100.0% -23.0% 18.5% 10.2%
FCF 188.00
224.00
246.00
363.00
929.00
443.00
487.00
825.00
685.00
901.00
647.00
growth rate 19.2% 9.8% 47.6% 155.9% -52.3% 9.9% 69.4% -17.0% 31.5% -28.2%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 1,447.00
1,678.60
1,899.60
2,045.50
2,322.90
2,493.70
2,963.70
3,435.30
3,722.80
4,348.00
4,386.30
growth rate 16.0% 13.2% 7.7% 13.6% 7.4% 18.9% 15.9% 8.4% 16.8% 0.9%
Op.Income 284.30
236.70
291.50
389.10
494.80
642.90
819.40
1,022.40
1,072.80
1,240.50
1,316.20
growth rate -16.7% 23.2% 33.5% 27.2% 29.9% 27.5% 24.8% 4.9% 15.6% 6.1%
IBT 268.20
283.60
388.20
511.20
1,144.00
622.40
737.90
1,034.90
761.40
1,166.50
916.70
growth rate 5.7% 36.9% 31.7% 123.8% -45.6% 18.6% 40.3% -26.4% 53.2% -21.4%
Net Income 218.00
236.70
291.50
389.10
811.10
494.90
569.50
583.60
722.20
1,046.90
823.40
growth rate 8.6% 23.2% 33.5% 108.5% -39.0% 15.1% 2.5% 23.8% 45.0% -21.4%
EPS 0.30
0.33
0.41
0.57
1.25
0.75
0.87
0.90
1.13
1.64
1.30
growth rate 10.0% 24.2% 39.0% 119.3% -40.0% 16.0% 3.5% 25.6% 45.1% -20.7%
Gross Profit 1,038.70
1,188.80
1,408.60
1,528.90
1,699.30
1,876.50
2,166.30
2,560.00
2,783.40
3,233.60
3,305.70
growth rate 14.5% 18.5% 8.5% 11.2% 10.4% 15.4% 18.2% 8.7% 16.2% 2.2%
R&D 204.40
246.30
291.30
323.00
346.50
382.90
442.20
552.60
622.20
752.70
760.70
growth rate 20.5% 18.3% 10.9% 7.3% 10.5% 15.5% 25.0% 12.6% 21.0% 1.1%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 310.80
368.40
229.80
357.20
360.80
growth rate 18.5% -37.6% 55.4% 1.0%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 599.10
585.10
567.90
671.70
602.80
growth rate -2.3% -2.9% 18.3% -10.3%
Acct.Payable 180.40
151.50
153.40
162.50
196.50
growth rate -16.0% 1.3% 5.9% 20.9%
Cur.Assets 2,984.00
2,507.90
2,690.30
2,980.40
3,091.00
growth rate -16.0% 7.3% 10.8% 3.7%
Total Assets 6,488.10
6,076.10
6,424.10
6,800.80
7,237.10
growth rate -6.4% 5.7% 5.9% 6.4%
Cash 1,179.10
662.90
903.50
1,024.00
1,183.20
growth rate -43.8% 36.3% 13.3% 15.6%
Inventory 640.90
662.20
735.10
773.30
802.30
growth rate 3.3% 11.0% 5.2% 3.8%
Cur.Liabilities 902.40
746.90
873.20
846.30
893.90
growth rate -17.2% 16.9% -3.1% 5.6%
Liabilities 2,636.60
2,175.00
2,585.00
2,590.50
2,662.80
growth rate -17.5% 18.9% 0.2% 2.8%
LT Debt 594.40
594.60
594.70
594.90
595.00
growth rate 0.0% 0.0% 0.0% 0.0%
Equity 4,148.30
3,901.10
3,839.10
4,210.30
4,574.30
growth rate -6.0% -1.6% 9.7% 8.7%
Common Shares 209.10
218.50
633.50
635.00
636.40
growth rate 4.5% 189.9% 0.2% 0.2%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 71.50
82.20
108.30
103.30
113.20
growth rate 15.0% 31.8% -4.6% 9.6%
Cash Dividends
growth rate
Cash From OA 399.40
207.00
231.20
216.10
400.00
growth rate -48.2% 11.7% -6.5% 85.1%
Sale Purchase of Stock
growth rate
FCF 327.90
124.80
122.90
112.80
286.80
growth rate -61.9% -1.5% -8.2% 154.3%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 1,152.10
1,128.70
925.00
1,140.90
1,191.70
growth rate -2.0% -18.1% 23.3% 4.5%
Op.Income 310.80
368.40
229.80
357.20
360.80
growth rate 18.5% -37.6% 55.4% 1.0%
IBT 315.50
364.50
-168.20
364.30
356.10
growth rate 15.5% -100.0% 100.0% -2.3%
Net Income 280.20
310.60
-121.90
325.20
309.50
growth rate 10.9% -100.0% 100.0% -4.8%
EPS
growth rate
Gross Profit 887.90
863.60
686.80
859.90
895.40
growth rate -2.7% -20.5% 25.2% 4.1%
R&D 193.90
187.40
182.10
195.50
195.70
growth rate -3.4% -2.8% 7.4% 0.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (67.76)

YOY Growth Grade:

C (62.72)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 65.15 66.15 34.29
EPS / Growth 25.8% 1.30 13.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 14.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 13.0% 17.8% 17.8%
Future PE 25.98 45.04 45.04
Future EPS 4.41 6.71 6.71
Value Price
MOS %
28.31
-67.1%
74.73
-13.1%
74.73
-13.1%
MOS Price 14.16 37.36 37.36
IRT 17.61 14.60 14.60

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.